"Our price target incorporates a prudent cost of capital and corresponds to a 2027 PE of only 10.1 times. The potential for growth in RO per share and the high level of capital return to shareholders remain significantly undervalued by the market," the analyst states.

With AXA set to release its 2025 results on February 26, the research firm forecasts revenues of 116.3 billion euros (+5.4% reported, +6.3% on a comparable basis), as well as RO per share of 3.84 EUR, in line with consensus and up 7%.

Oddo BHF also anticipates an attractive capital return to shareholders, expecting a dividend per share of 2.29 EUR (+6.5%), slightly below consensus (2.31 EUR), and a share buyback of 1.3 billion EUR for 2025.